Aberrantly regulated dysadherin and B-cell lymphoma 2/B-cell lymphoma 2-associated X enhances tumorigenesis and DNA targeting drug resistance of liver cancer stem cells

Cancer stem cells (CSCs) in hepatocellular carcinoma (HCC) are frequently resistant to current therapeutic regimens and therefore responsible for tumor recurrence. Previous studies have reported that expression levels of dysadherin in CSCs may be used as a prognostic indicator, which is also respons...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Med Rep
Päätekijät: JIANG, NAN, CHEN, WEI, ZHANG, JIAN-WEN, LI, YANG, ZENG, XIAN-CHENG, ZHANG, TONG, FU, BIN-SHENG, YI, HUI-MIN, ZHANG, QI
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: D.A. Spandidos 2015
Aiheet:
Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4626168/
https://ncbi.nlm.nih.gov/pubmed/26458963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2015.4363
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia